Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
To compare the concordance in risk classification between the EndoPredict and the MammaPrint scores obtained for the same cancer samples on 40 estrogen-receptor positive/HER2-negative breast carcinomas.Formalin-fixed, paraffin-embedded invasive breast carcinoma tissues that were previously analyzed...
Main Authors: | Alberto Peláez-García, Laura Yébenes, Alberto Berjón, Antonia Angulo, Pilar Zamora, José Ignacio Sánchez-Méndez, Enrique Espinosa, Andrés Redondo, Victoria Heredia-Soto, Marta Mendiola, Jaime Feliú, David Hardisson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5590847?pdf=render |
Similar Items
-
MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.
by: Andreas Bösl, et al.
Published: (2017-01-01) -
Prognostic Value of MammaPrint in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-01-01) -
Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-12-01) -
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
by: Hatem Soliman, et al.
Published: (2020-01-01) -
MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience
by: C. Francisco Espinel, et al.
Published: (2012-01-01)